| Biotechnology Industry | Healthcare Sector | Mr. Charalambos Katevatis CEO | TSX-V Exchange | - ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Zenith Capital Corporation, established in 2019 and headquartered in Vancouver, Canada, currently does not engage in significant operational activities. Its primary goal is to explore and assess various businesses or assets with the aim of executing a qualifying transaction. This approach positions Zenith Capital Corporation as a strategic entity focused on identifying promising opportunities for investment and growth in various sectors.
As Zenith Capital Corporation is in the phase of identifying and evaluating potential businesses or assets for a qualifying transaction, it does not offer traditional products or services. Its activities are centered around: